logo

STRO

Sutro Biopharma·NASDAQ
--
--(--)
--
--(--)

STRO fundamentals

Sutro Biopharma (STRO) released its earnings on Aug 7, 2025: revenue was 63.74M (YoY +147.98%), beat estimates; EPS was -1.4 (YoY +76.27%), beat estimates.
Revenue / YoY
63.74M
+147.98%
EPS / YoY
-1.4
+76.27%
Report date
Aug 7, 2025
Earnings Call
4:00 PM on Aug 7, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

STRO has released its 2025 Q4 earnings report, with revenue of 11.65M, reflecting a YoY change of -21.35%, and net profit of -46.76M, showing a YoY change of 35.45%. The Sankey diagram below clearly presents STRO's revenue sources and cost distribution.

Key Indicators

Sutro Biopharma (STRO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Sutro Biopharma (STRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Sutro Biopharma (STRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Sutro Biopharma (STRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Sutro Biopharma (STRO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Sutro Biopharma (STRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield